Pancreatic Cancer Research

ResearcherVA Nebraska Western Iowa Health Care SystemNo recent work listed

Viswanathan Saraswathi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6721-9600; OpenAlex author ID A5011014272. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant-Antioxidant Balance. Last author DOI 10.3390/cancers15092593↗
  2. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Co-author DOI 10.1186/s13046-018-0963-4↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 2 shared papers, 2018–2023 · strength 0.26
  2. Satyanarayana Rachagani · 2 shared papers, 2018–2023 · strength 0.26
  3. Robert Powers · 1 shared paper, 2023 · strength 0.17
  4. Narendra Kumar · 1 shared paper, 2023 · strength 0.17
  5. Jyoti Kaushal · 1 shared paper, 2023 · strength 0.17
  6. Nagabhishek Sirpu Natesh · 1 shared paper, 2023 · strength 0.17
  7. Sanjib Chaudhary · 1 shared paper, 2018 · strength 0.09
  8. Ramesh Pothuraju · 1 shared paper, 2018 · strength 0.09
  9. Sukhwinder Kaur · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.